DK1232141T3 - Ethere af O-desmethylvenlafaxin - Google Patents
Ethere af O-desmethylvenlafaxinInfo
- Publication number
- DK1232141T3 DK1232141T3 DK00980588T DK00980588T DK1232141T3 DK 1232141 T3 DK1232141 T3 DK 1232141T3 DK 00980588 T DK00980588 T DK 00980588T DK 00980588 T DK00980588 T DK 00980588T DK 1232141 T3 DK1232141 T3 DK 1232141T3
- Authority
- DK
- Denmark
- Prior art keywords
- desmethylvenlafaxine
- ethers
- Prior art date
Links
- KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 title 1
- 150000002170 ethers Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44826899A | 1999-11-24 | 1999-11-24 | |
| PCT/US2000/031895 WO2001038293A1 (en) | 1999-11-24 | 2000-11-21 | Ethers of o-desmethyl venlafaxine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1232141T3 true DK1232141T3 (da) | 2004-11-29 |
Family
ID=23779642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00980588T DK1232141T3 (da) | 1999-11-24 | 2000-11-21 | Ethere af O-desmethylvenlafaxin |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1232141B1 (cs) |
| JP (1) | JP2003514889A (cs) |
| KR (1) | KR100843991B1 (cs) |
| CN (2) | CN1636559A (cs) |
| AR (1) | AR024498A1 (cs) |
| AT (1) | ATE278659T1 (cs) |
| AU (1) | AU767835B2 (cs) |
| BR (1) | BR0015795A (cs) |
| CA (1) | CA2391288A1 (cs) |
| CZ (1) | CZ20021816A3 (cs) |
| DE (1) | DE60014693T2 (cs) |
| DK (1) | DK1232141T3 (cs) |
| ES (1) | ES2228636T3 (cs) |
| HU (1) | HUP0203594A2 (cs) |
| IL (2) | IL149531A0 (cs) |
| MX (1) | MXPA02005174A (cs) |
| NO (1) | NO20022446L (cs) |
| NZ (1) | NZ519130A (cs) |
| PL (1) | PL202846B1 (cs) |
| PT (1) | PT1232141E (cs) |
| SI (1) | SI1232141T1 (cs) |
| TW (1) | TWI268919B (cs) |
| WO (1) | WO2001038293A1 (cs) |
| ZA (1) | ZA200204986B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| CN103588653B (zh) * | 2010-10-01 | 2015-04-22 | 山东绿叶制药有限公司 | 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用 |
| CN103319373B (zh) * | 2012-03-23 | 2017-09-19 | 浙江九洲药业股份有限公司 | 1‑[2‑氨基‑1‑(4‑苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体 |
-
2000
- 2000-11-21 PL PL355171A patent/PL202846B1/pl not_active IP Right Cessation
- 2000-11-21 AU AU17833/01A patent/AU767835B2/en not_active Ceased
- 2000-11-21 AT AT00980588T patent/ATE278659T1/de not_active IP Right Cessation
- 2000-11-21 CN CNA2004100882450A patent/CN1636559A/zh active Pending
- 2000-11-21 ES ES00980588T patent/ES2228636T3/es not_active Expired - Lifetime
- 2000-11-21 MX MXPA02005174A patent/MXPA02005174A/es active IP Right Grant
- 2000-11-21 HU HU0203594A patent/HUP0203594A2/hu unknown
- 2000-11-21 DE DE60014693T patent/DE60014693T2/de not_active Expired - Fee Related
- 2000-11-21 IL IL14953100A patent/IL149531A0/xx unknown
- 2000-11-21 CN CNB008161496A patent/CN1198793C/zh not_active Expired - Fee Related
- 2000-11-21 DK DK00980588T patent/DK1232141T3/da active
- 2000-11-21 CA CA002391288A patent/CA2391288A1/en not_active Abandoned
- 2000-11-21 KR KR1020027006602A patent/KR100843991B1/ko not_active Expired - Fee Related
- 2000-11-21 BR BR0015795-3A patent/BR0015795A/pt not_active Application Discontinuation
- 2000-11-21 WO PCT/US2000/031895 patent/WO2001038293A1/en not_active Ceased
- 2000-11-21 EP EP00980588A patent/EP1232141B1/en not_active Expired - Lifetime
- 2000-11-21 NZ NZ519130A patent/NZ519130A/en unknown
- 2000-11-21 JP JP2001539850A patent/JP2003514889A/ja not_active Withdrawn
- 2000-11-21 CZ CZ20021816A patent/CZ20021816A3/cs unknown
- 2000-11-21 PT PT00980588T patent/PT1232141E/pt unknown
- 2000-11-21 SI SI200030509T patent/SI1232141T1/xx unknown
- 2000-11-22 AR ARP000106165A patent/AR024498A1/es unknown
- 2000-11-23 TW TW089124917A patent/TWI268919B/zh not_active IP Right Cessation
-
2002
- 2002-05-08 IL IL149531A patent/IL149531A/en not_active IP Right Cessation
- 2002-05-23 NO NO20022446A patent/NO20022446L/no not_active Application Discontinuation
- 2002-06-20 ZA ZA200204986A patent/ZA200204986B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL149531A0 (en) | 2002-11-10 |
| AU1783301A (en) | 2001-06-04 |
| ES2228636T3 (es) | 2005-04-16 |
| KR100843991B1 (ko) | 2008-07-07 |
| PL355171A1 (en) | 2004-04-05 |
| AU767835B2 (en) | 2003-11-27 |
| HUP0203594A2 (en) | 2003-02-28 |
| ZA200204986B (en) | 2003-09-27 |
| DE60014693T2 (de) | 2005-03-10 |
| NZ519130A (en) | 2003-09-26 |
| PL202846B1 (pl) | 2009-07-31 |
| NO20022446D0 (no) | 2002-05-23 |
| EP1232141B1 (en) | 2004-10-06 |
| MXPA02005174A (es) | 2002-11-07 |
| CZ20021816A3 (cs) | 2002-08-14 |
| CN1399626A (zh) | 2003-02-26 |
| SI1232141T1 (en) | 2004-12-31 |
| IL149531A (en) | 2008-12-29 |
| CN1198793C (zh) | 2005-04-27 |
| KR20030058931A (ko) | 2003-07-07 |
| CN1636559A (zh) | 2005-07-13 |
| NO20022446L (no) | 2002-05-23 |
| DE60014693D1 (en) | 2004-11-11 |
| AR024498A1 (es) | 2002-10-02 |
| WO2001038293A1 (en) | 2001-05-31 |
| EP1232141A1 (en) | 2002-08-21 |
| PT1232141E (pt) | 2004-12-31 |
| JP2003514889A (ja) | 2003-04-22 |
| BR0015795A (pt) | 2002-07-23 |
| ATE278659T1 (de) | 2004-10-15 |
| HK1045835A1 (en) | 2002-12-13 |
| TWI268919B (en) | 2006-12-21 |
| CA2391288A1 (en) | 2001-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05421B1 (et) | Fulvestrandi formulatsioonid | |
| DE60114714D1 (de) | Silikon-Entschäumer-Zusammensetzung | |
| IS2325B (is) | Örgerðar samsetningar epleróns | |
| DE69933200D1 (de) | Kombinierte impfstoffzusammensetzungen | |
| ATE476975T1 (de) | Abführende zusammensetzungen | |
| FI20010780A0 (fi) | Parannetut koostumukset | |
| NO20003815D0 (no) | Sammensetninger omfattende celecoxib | |
| DK1309327T3 (da) | Farmaceutiske sammensætninger af østrogene midler | |
| DK1237408T3 (da) | Hæld-på-formuleringer | |
| PT1250321E (pt) | Composicao de gliburida | |
| DE60100687D1 (de) | Netzartige Silikonpolymerzusammensetzungen | |
| EP1438323A4 (en) | ADJUVOUS MENINGOCOCCUS COMPOSITIONS | |
| DE50203030D1 (de) | Befeuchtungszelle | |
| DK1337228T3 (da) | Sammensætninger til fjernelse af human cerumen | |
| DE60007044D1 (de) | Stabile biozide Zusammensetzungen | |
| PT1238587E (pt) | Composicoes de biopesticidas | |
| DE60103258D1 (de) | Gesicherte dienste | |
| LU90483B1 (fr) | Compositions nouvelles de m-thanesulfonate de parox-tine | |
| IS6620A (is) | Nýr fjölgervingur V af tórasemíði | |
| DK1140068T3 (da) | Doramectin formulations | |
| FI20011778A0 (fi) | Ryhmälähetyksen toteutus | |
| DK1088010T3 (da) | Fremstilling af polyolefiner | |
| DK1358781T3 (da) | Faceplate | |
| NO20030946D0 (no) | Medisinske sammensetninger | |
| NO20022446L (no) | Etere av O-desmetyl-venlafaxine |